Upregulated pirin (PIR) facilitates colorectal cancer (CRC) survival by suppressing Fas‐mediated apoptosis in two ways, namely, the disruption of NFκB2‐driven FAS transcription and the attenuation of FAS membrane translocation and assembling. This evidence concerns the gene FAS and colorectal cancer.